Literature DB >> 14713721

TRAIL, Bim, and thymic-negative selection.

Shi-Jun Zheng1, Youhai H Chen.   

Abstract

Negative selection is a process whereby autoreactive lymphocytes are deleted through apoptosis. Negative selection is essential for self-tolerance and its breakdown may lead to the development of autoimmune diseases. Although the phenomenon of negative selection is well-recognized, its underlying molecular mechanisms are unclear. Recent studies using gene-knockout mice have provided new insights into the mechanisms of negative selection. In this review, we discuss the newly discovered roles of TRAIL and Bim in negative selection. Our main focus will be on T cells and T cell mediated autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14713721     DOI: 10.1385/IR:28:3:295

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  50 in total

Review 1.  Intrathymic and extrathymic clonal deletion of T cells.

Authors:  J Sprent; S R Webb
Journal:  Curr Opin Immunol       Date:  1995-04       Impact factor: 7.486

2.  BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak.

Authors:  W X Zong; T Lindsten; A J Ross; G R MacGregor; C B Thompson
Journal:  Genes Dev       Date:  2001-06-15       Impact factor: 11.361

3.  TRAIL/Apo-2 ligand induces primary plasma cell apoptosis.

Authors:  Josie Ursini-Siegel; Wenli Zhang; Anne Altmeyer; Eunice N Hatada; Richard K G Do; Hideo Yagita; Selina Chen-Kiang
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

4.  TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL.

Authors:  G R Screaton; J Mongkolsapaya; X N Xu; A E Cowper; A J McMichael; J I Bell
Journal:  Curr Biol       Date:  1997-09-01       Impact factor: 10.834

5.  Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.

Authors:  J P Sheridan; S A Marsters; R M Pitti; A Gurney; M Skubatch; D Baldwin; L Ramakrishnan; C L Gray; K Baker; W I Wood; A D Goddard; P Godowski; A Ashkenazi
Journal:  Science       Date:  1997-08-08       Impact factor: 47.728

6.  TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB.

Authors:  P Schneider; M Thome; K Burns; J L Bodmer; K Hofmann; T Kataoka; N Holler; J Tschopp
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

7.  The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice.

Authors:  H K Sytwu; R S Liblau; H O McDevitt
Journal:  Immunity       Date:  1996-07       Impact factor: 31.745

8.  TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling.

Authors:  G Pan; J Ni; G Yu; Y F Wei; V M Dixit
Journal:  FEBS Lett       Date:  1998-03-06       Impact factor: 4.124

9.  BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis.

Authors:  E H Cheng; M C Wei; S Weiler; R A Flavell; T W Mak; T Lindsten; S J Korsmeyer
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

Review 10.  Influence of viral superantigens on V beta- and V alpha-specific positive and negative selection.

Authors:  K Tomonari; S Fairchild; O A Rosenwasser
Journal:  Immunol Rev       Date:  1993-02       Impact factor: 12.988

View more
  4 in total

Review 1.  Are we really on the right TRAIL?

Authors:  Erika Cretney; Adam P Uldrich; Stuart P Berzins; Andreas Strasser; Dale I Godfrey; Mark J Smyth
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

2.  Preclinical efficacy of sodium narcistatin to reduce inflammation and joint destruction in rats with adjuvant-induced arthritis.

Authors:  Cheri Lubahn; Jill A Schaller; Eric Shewmacker; Carlo Wood; Denise L Bellinger; Donna Byron; Noeleen Melody; George R Pettit; Dianne Lorton
Journal:  Rheumatol Int       Date:  2011-12-09       Impact factor: 2.631

3.  CD4(+)CD25(+) regulatory T cells resist a novel form of CD28- and Fas-dependent p53-induced T cell apoptosis.

Authors:  Nagendra Singh; Mutsumi Yamamoto; Mariko Takami; Yoichi Seki; Mayuko Takezaki; Andrew L Mellor; Makio Iwashima
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

4.  IFN-α is constitutively expressed in the human thymus, but not in peripheral lymphoid organs.

Authors:  Arnaud D Colantonio; Marta Epeldegui; Maria Jesiak; Loes Jachimowski; Bianca Blom; Christel H Uittenbogaart
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.